Historical data shows that a consistent $500 monthly investment into Regencell Bioscience Holdings Limited (RGC) starting in 2020 would have turned a total investment of $40K into $749K today. This represents a total return of 1796.9% over the 6-year period, compounding through dividend reinvestment and market growth.
The Impact of Dividend Reinvestment (DRIP)
Regencell Bioscience Holdings Limited does not currently pay a notable dividend. For growth-focused stocks like RGC, dollar cost averaging relies entirely on price appreciation. Over the 6-year period, the strategy successfully captured the stock's price movements, resulting in a final portfolio value of $749K without the need for dividend reinvestment.
RGC vs. S&P 500 (SPY) Benchmark
When comparing this dollar cost averaging strategy against a broad market index,RGC outperformed the S&P 500 ETF (SPY). The same $500 monthly contributions into SPY would have grown to $60K, compared to RGC's $749K.